Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason M Pogue

Showing results (31-40 of 167) with videos related to

Pageof 17
Sort By:
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2023
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosaOwen R Albin, Jason M Pogue, Richard G Wunderink, et al.
Drugs|February 7, 2019
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial InfectionsKhalid Eljaaly, Aisha Alharbi, Samah Alshehri, et al.
Expert Review of Anti-Infective Therapy|July 18, 2015
Strategies for the safe use of colistinJessica K Ortwine, Jesse D Sutton, Keith S Kaye, et al.
BMJ Evidence-Based Medicine|November 17, 2022
What is the place in therapy for nirmatrelvir/ritonavir?Todd C Lee, Jason M Pogue, Erin K McCreary, et al.
Pageof 17

Showing results (31-40 of 167) with videos related to

Sort By:
Pageof 17
Pharmacotherapy|September 20, 2011
Revisiting "older" antimicrobials in the era of multidrug resistanceJason M Pogue, Dror Marchaim, Donald Kaye, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 7, 2020
Reply to Vena et alJason M Pogue, Keith S Kaye, Robert A Bonomo, et al.
Expert Review of Anti-Infective Therapy|April 10, 2013
Carbapenem-resistant Acinetobacter baumannii: epidemiology, surveillance and managementJason M Pogue, Tal Mann, Katie E Barber, et al.
Infectious Diseases and Therapy|March 31, 2017
Minocycline for the Treatment of Multidrug and Extensively Drug-Resistant A. baumannii: A ReviewJennifer N Lashinsky, Oryan Henig, Jason M Pogue, et al.
Infectious Diseases and Therapy|February 27, 2023
Cefiderocol, a Siderophore Cephalosporin, as a Treatment Option for Infections Caused by Carbapenem-Resistant EnterobacteralesKeith S Kaye, Thierry Naas, Jason M Pogue, et al.
Pharmacotherapy|September 5, 2014
Colistin: understanding and applying recent pharmacokinetic advancesJessica K Ortwine, Keith S Kaye, Jian Li, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|July 10, 2023
Which trial do we need? Combination antimicrobial therapy for hospital-acquired bacterial pneumonia caused by Pseudomonas aeruginosaOwen R Albin, Jason M Pogue, Richard G Wunderink, et al.
Drugs|February 7, 2019
Plazomicin: A Novel Aminoglycoside for the Treatment of Resistant Gram-Negative Bacterial InfectionsKhalid Eljaaly, Aisha Alharbi, Samah Alshehri, et al.
Expert Review of Anti-Infective Therapy|July 18, 2015
Strategies for the safe use of colistinJessica K Ortwine, Jesse D Sutton, Keith S Kaye, et al.
BMJ Evidence-Based Medicine|November 17, 2022
What is the place in therapy for nirmatrelvir/ritonavir?Todd C Lee, Jason M Pogue, Erin K McCreary, et al.
Pageof 17